• Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
  • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
Australian-market-dragged-down-lower-commodity-prices-July-2022

Weekly review: Australian market dragged down by lower commodity prices

After bravely heading in the opposite direction to Wall Street for most of Friday, the...

Wellnex-Life-ASX-WNX-revenue-increase-FY2022-growth

Wellnex Life increases FY2022 revenue, with accelerated growth to continue

 Wellnex Life (ASX: WNX) has revealed a 6.6% increase in unaudited revenue for the financial year...

GettyImages-130418879739-640x360

Wellnex delivers full year revenue lift despite global supply chain glut, says FY23 revenue will now jump by 50%

Aussie health and wellness company Wellnex Life Limited (ASX: WNX) says unaudited revenue jumped by...

wellnex

Potentially undervalued Wellnex Life ‘demands rerating’: Report

Health and wellness brands company Wellnex Life should be worth more than three times its...

man running

Pitt Street Research: Wellnex Life (ASX: WNX)

Pitt Street Research have published research on Wellnex Life, providing an overview of the Company,...

WNX

Investors throw support behind Wellnex’s digital marketplace

Wellnex Life has successfully raised more than $6 million from investors to finance its wholly...

image-for-resize-640x360

Wellnex raises $6.2 million to fast-track entry into OTC medicinal cannabis market

Wellnex Life has secured the funds to fast-track its entry into the newly opened-up and...

Wellnex-Life-in-race-to-be-one-of-Australia-s-early-OTC-cannabidiol-winners

Fast and furious: Wellnex Life in race to be one of Australia’s early pharmacy OTC cannabidiol winners

Preparations are underway in registering its schedule 3 medicinal cannabis product, which CEO George Karafotias...

image2-1-640x360

Wellnex set to launch direct-to-consumer platform to escape inflation pressure cooker & boost margins

Wellnex will launch a new direct-to-consumer platform to fast-track profitability and ease inflation pressures. Health...

Happy family: mother, father, children son and  daughter on nature  on sunset

‘Strong quarter’: Wellnex books 44% increase in sales revenue

Wellnex Life experiences another quarter of strong revenue growth with strong organic growth across brands...

Posts pagination

Previous 1 … 7 8 9 … 15 Next
RECENT POSTS
  • Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
  • Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024
  • Wellnex ready for dual UK listing in new year after record November sales
  • ASX wellness stocks offering calm and anxiety relief – Part 2
  • Wellnex Life (ASX:WNX) Q&A – 9th February 2024
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2022 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)